close
This ad will auto close in 10 seconds

Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for USD8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.